The post argues the drugs are shifting American spending away from bigger portions and impulse buys, reshaping a consumer economy built on more.
Recap by typeshit. Post by @masterclass on Instagram.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
With retatrutide trials showing losses near 29%, doctors quoted by Medscape describe when weight loss may be going too far and lost strength calls for a rethink.
She points out that some of the weight lost on Ozempic, Wegovy or Mounjaro can be muscle, and argues this matters more in midlife. It's general advice, not new research.
Loading…